Diong, Roland C.

HRN: 21-51-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/29/2022
07/06/2022
IV
600
Q8
Diabetic Foot
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes